ACYCLOVIR SODIUM - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for acyclovir sodium and what is the scope of patent protection?
Acyclovir sodium
is the generic ingredient in four branded drugs marketed by Abbvie, Eurohlth Intl Sarl, Apothecon, Chartwell Injectable, Dr Reddys, Eugia Pharma, Fresenius Kabi Usa, Hainan Poly, Hikma, Hospira, Norvium Bioscience, Teva Parenteral, Zydus Pharms, and Glaxosmithkline, and is included in twenty-two NDAs. Additional information is available in the individual branded drug profile pages.There are three drug master file entries for acyclovir sodium. Nine suppliers are listed for this compound.
Summary for ACYCLOVIR SODIUM
US Patents: | 0 |
Tradenames: | 4 |
Applicants: | 14 |
NDAs: | 22 |
Drug Master File Entries: | 3 |
Finished Product Suppliers / Packagers: | 9 |
Raw Ingredient (Bulk) Api Vendors: | 231 |
Clinical Trials: | 7 |
Patent Applications: | 884 |
Drug Prices: | Drug price trends for ACYCLOVIR SODIUM |
What excipients (inactive ingredients) are in ACYCLOVIR SODIUM? | ACYCLOVIR SODIUM excipients list |
DailyMed Link: | ACYCLOVIR SODIUM at DailyMed |
Recent Clinical Trials for ACYCLOVIR SODIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Sohag University | Phase 4 |
Haining Health-Coming Biotech Co., Ltd. | Phase 2 |
Alphacait, LLC | Phase 2 |
Pharmacology for ACYCLOVIR SODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fresenius Kabi Usa | ACYCLOVIR SODIUM | acyclovir sodium | INJECTABLE;INJECTION | 075015-001 | Apr 30, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hikma | ACYCLOVIR SODIUM | acyclovir sodium | INJECTABLE;INJECTION | 205771-002 | Feb 29, 2016 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Glaxosmithkline | ZOVIRAX | acyclovir sodium | INJECTABLE;INJECTION | 018603-003 | Aug 30, 1983 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hospira | ACYCLOVIR SODIUM | acyclovir sodium | INJECTABLE;INJECTION | 074758-001 | Apr 22, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Eugia Pharma | ACYCLOVIR SODIUM | acyclovir sodium | INJECTABLE;INJECTION | 203701-001 | Oct 11, 2013 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Teva Parenteral | ACYCLOVIR SODIUM | acyclovir sodium | INJECTABLE;INJECTION | 074969-002 | Aug 26, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ACYCLOVIR SODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxosmithkline | ZOVIRAX | acyclovir sodium | INJECTABLE;INJECTION | 018603-001 | Oct 22, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.